Agilent Technologies acquires manufacturer of synthetic nucleic acids for pharmaceutical and biotech industries
Acquisition addresses rapidly growing RNA synthesis market
19-Apr-2006 -
Agilent Technologies Inc. announced that it has acquired privately held SynPro Corp., the owner of a contract manufacturing facility established to supply active pharmaceutical ingredients and provide related services. Financial details were not disclosed.
Based in Boulder, Colo., the facility ...
acids
active pharmaceutical ingredients
Agilent Technologies
+5